Cutia Therapeutics (2487.HK)

HKD 6.95

(0.14%)

Operating Expenses Summary of Cutia Therapeutics

  • Cutia Therapeutics's latest annual operating expenses in 2023 was 71 Million CNY , up 92.34% from previous year.
  • Cutia Therapeutics's latest quarterly operating expenses in 2024 Q2 was 135.04 Million CNY , down 0.0% from previous quarter.
  • Cutia Therapeutics reported a annual operating expenses of 310.89 Million CNY in annual operating expenses 2022, up 74.26% from previous year.
  • Cutia Therapeutics reported a annual operating expenses of 178.41 Million CNY in annual operating expenses 2021, down 0.0% from previous year.
  • Cutia Therapeutics reported a quarterly operating expenses of 135.04 Million CNY for 2024 Q1, down -27.89% from previous quarter.
  • Cutia Therapeutics reported a quarterly operating expenses of 187.27 Million CNY for 2023 Q4, down -1.68% from previous quarter.

Annual Operating Expenses Chart of Cutia Therapeutics (2023 - 2021)

Historical Annual Operating Expenses of Cutia Therapeutics (2023 - 2021)

Year Operating Expenses Operating Expenses Growth
2023 71 Million CNY 92.34%
2022 310.89 Million CNY 74.26%
2021 178.41 Million CNY 0.0%

Peer Operating Expenses Comparison of Cutia Therapeutics

Name Operating Expenses Operating Expenses Difference
Uni-Bio Science Group Limited 325.05 Million HKD 78.155%
CK Life Sciences Int'l., (Holdings) Inc. 739.25 Million HKD 90.395%